Diminished levels of nasal S100A7 (psoriasin) in seasonal allergic rhinitis: an effect mediated by Th2 cytokines
Open Access
- 1 January 2012
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 13 (1) , 2
Abstract
S100A7 is an antimicrobial peptide involved in several inflammatory diseases. The aim of the present study was to explore the expression and regulation of S100A7 in seasonal allergic rhinitis (SAR).Keywords
This publication has 39 references indexed in Scilit:
- S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancerOncogene, 2010
- Chemotactic Activity of S100A7 (Psoriasin) Is Mediated by the Receptor for Advanced Glycation End Products and Potentiates Inflammation with Highly Homologous but Functionally Distinct S100A15The Journal of Immunology, 2008
- Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomasThorax, 2008
- Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activationImmunology, 2008
- Expression of S100 protein family members in the pathogenesis of bladder tumors.2007
- Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumoursJournal of Cancer Research and Clinical Oncology, 2006
- Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infectionNature Immunology, 2004
- S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)Biochemical and Biophysical Research Communications, 2004
- Psoriasin: A Novel Chemotactic ProteinJournal of Investigative Dermatology, 1996
- Molecular Cloning, Occurrence, and Expression of a Novel Partially Secreted Protein “Psoriasin” That Is Highly Up-Regulated in Psoriatic SkinJournal of Investigative Dermatology, 1991